Personas / Equipo Humano

Joan Calzada Hernández

Buscador de publicaciones

Publicaciones

  • Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, García de Vicuña-Muñoz C, Zilhao C, Yeh S, Anton-Lopez J and Calzada-Hernández J.

    Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

    PEDIATRIC RHEUMATOLOGY . 17(1): 66-66. Nº de citas: 33

    [doi:10.1186/s12969-019-0345-2]

  • Martos-Moreno GA, Calzada-Hernández J, Couce ML and Argente J.

    Hypophosphatasia: clinical manifestations, diagnostic recommendations and therapeutic options

    ANALES DE PEDIATRIA . 88(6): 356-356. Nº de citas: 14

    [doi:10.1016/j.anpedi.2017.06.004]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Rodó X and Morguí JA.

    Kawasaki disease is more prevalent in rural areas of Catalonia (Spain)

    ANALES DE PEDIATRIA . 87(4): 226-231. Nº de citas: 4

    [doi:10.1016/j.anpedi.2016.12.009]

  • Guerrero-Laleona C, Calzada-Hernández J, Bustillo-Alonso M, Gil-Albarova J, Medrano-San Ildefonso M, Iglesias-Jimenez E and Noguera-Julian A.

    DISSEMINATED TUBERCULOSIS RESULTING FROM REINFECTION IN A PEDIATRIC PATIENT SEQUENTIALLY TREATED WITH ETANERCEPT AND ADALIMUMAB

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 36(1): 109-110. Nº de citas: 8

    [doi:10.1097/INF.0000000000001360]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.

    Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

    RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de citas: 31

    [doi:10.1007/s00296-016-3499-y]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.

    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de citas: 15

  • Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julian A.

    Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study

    PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de citas: 35

    [doi:10.1186/s12969-015-0054-4]

  • Serrano A, Caurín MB, Calzada-Hernández J and Launes-Montana C.

    Lactant amb febre i impotència funcional de l'extremitat superior

    Pediatría Catalana . 75(1): 21-22.

  • Giménez-Roca CI, Iglesias-Jimenez E, Torrente-Segarra V, Bou-Torrent R, Sánchez-Manubens J, Calzada-Hernández J, Samuel Hernandez Baldizon, Ricart S and Anton-Lopez J.

    Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age

    RHEUMATOLOGY INTERNATIONAL . 35(2): 323-326. Nº de citas: 12

    [doi:10.1007/s00296-014-3103-2]

  • Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.

    Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-a therapy: a clinical practice observational study of patients who discontinued treatment

    RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de citas: 25

    [doi:10.1007/s00296-013-2884-z]